LOGIFARMA STARTS OPERATIONS WITH PHARMAMAR AND STRENGTHENS LEADERSHIP IN BIOTECHNOLOGY

In January 2015, Logifarma started logistics operations and distribution of the product Yondelis in the Portuguese hospital market. This molecule, indicated for the treatment of soft tissue sarcomas and ovarian cancer, is an important innovation in the treatment of all those who in everyday life have to fight against cancer.

Founded in 1986, is currently a member of the Zeltia Group, PharmaMar is a biotechnology company that is determined to advance in the treatment of cancers, constituting itself as a pioneer in the discovery, development, production and promotion of innovative molecules of marine origin.

The operations started on January 10 this year, having so far been carried out more than 90 deliveries in 18 different hospital units of Mainland Portugal and the autonomous regions, no record of any occurrence, which is the best testimony to the quality and reliability of the Logifarma solution, and a pride to the two companies.

Carla Bretes (Responsible in Portugal), considers the operation with Logifarma, as a work of excellence, both as a real partner in Portugal on PharmaMar’s disclosure as the quality service it provides to our customers.

The Logifarma option has proved so as a bet won by Pharmarmar in Portugal.

In addition to a logistics operation of excellence, the partnership was extended to all administrative processes necessary for business in Portugal: Billing; Credit control; response to hospital contests, etc. which resulted in a greater capacity of the commercial team and support business development.